CCMU
NKTR icon

Cheyne Capital Management (UK)’s Nektar Therapeutics NKTR Stock Holding History

Cheyne Capital Management (UK)’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-11,487
Closed -$1.89M – 40
2015
Q3 		$1.89M Sell
11,487
-11,424
-50% -$2.02M 0.89% 16
2015
Q2 		$4.3M Sell
22,911
-16,373
-42% -$2.82M 1.39% 10
2015
Q1 		$6.48M Buy
39,284
+16,056
+69% +$3.3M 1.56% 14
2014
Q4 		$5.4M Buy
23,228
+7,923
+52% +$1.69M 1.42% 13
2014
Q3 		$2.77M Buy
+15,305
New +$2.93M 0.99% 16

Other funds holding NKTR

O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Cheyne Capital Management (UK)'s NKTR Position: Q4 2015 in Review

Cheyne Capital Management (UK) sold out of Nektar Therapeutics (NKTR) in Q4 2015, closing a stake of 11,487 shares — an estimated $1.89M sold.

Cheyne Capital Management (UK) first reported a position in NKTR in Q3 2014 and held it in 5 quarters. The position peaked at $6.48M in Q1 2015. 179 funds tracked by Wall St. Rank hold NKTR as of Q4 2015.

  • Cheyne Capital Management (UK) reported no remaining Nektar Therapeutics position as of Q4 2015 after selling out during the quarter.
  • Cheyne Capital Management (UK) sold 11,487 Nektar Therapeutics shares in Q4 2015, an estimated $1.89M.
  • Cheyne Capital Management (UK) first reported a position in Nektar Therapeutics in Q3 2014 and held it in 5 quarters.
  • Cheyne Capital Management (UK)'s Nektar Therapeutics position peaked at $6.48M in Q1 2015.
  • 179 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q4 2015.

Based on Cheyne Capital Management (UK)'s 13F filing for Q4 2015, filed 15 Jan 2016.